Balentine LLC’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-69
Closed -$34K 671
2017
Q3
$34K Buy
+69
New +$34K ﹤0.01% 321